Published in Biomed Res Int on March 26, 2014
Association Between Autonomic Impairment and Structural Deficit in Parkinson Disease. Medicine (Baltimore) (2016) 0.80
Longitudinal brain structural alterations and systemic inflammation in obstructive sleep apnea before and after surgical treatment. J Transl Med (2016) 0.76
Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease. Oxid Med Cell Longev (2016) 0.76
Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson's Disease. Oxid Med Cell Longev (2017) 0.75
Associations among Cognitive Functions, Plasma DNA, and White Matter Integrity in Patients with Early-Onset Parkinson's Disease. Front Neurosci (2017) 0.75
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology (1992) 6.03
Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol (2009) 4.88
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord (2004) 4.83
Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol (2005) 2.38
Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol (1988) 2.28
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett (1994) 2.27
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord (2002) 2.23
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience (1996) 2.06
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci (2000) 1.66
Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology (2006) 1.51
Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol (1998) 1.47
Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord (2005) 1.36
Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A (1994) 1.33
Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide-injected brain. Glia (2007) 1.19
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism. J Neuroimmunol (2001) 1.18
Interleukin (IL)-1 beta, IL-6, tumor necrosis factor-alpha, epidermal growth factor, and beta 2-microglobulin levels are elevated in gingival crevicular fluid during human orthodontic tooth movement. J Dent Res (1996) 1.18
Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J Nucl Med (2004) 1.00
Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. J Nucl Med (2004) 0.97
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol Sci (2001) 0.97
Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons. J Neural Transm (Vienna) (2004) 0.95
Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiol Dis (2010) 0.95
Parkinson's disease risk factors: genetic, environmental, or both? Neurol Res (2005) 0.93
Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence. Parkinsons Dis (2011) 0.91
[99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med (1997) 0.89
Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration. Neurobiol Aging (2008) 0.88
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage. Neurobiol Dis (2006) 0.88
In vivo administration of L-dopa or dopamine decreases the number of splenic IFN gamma-producing cells. J Neuroimmunol (2003) 0.87
Leucocyte apoptosis in patients with acute ischaemic stroke. Clin Exp Pharmacol Physiol (2010) 0.78
Elevated serum vascular cell adhesion molecule-1 is associated with septic encephalopathy in adult community-onset severe sepsis patients. Biomed Res Int (2014) 0.78
Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease. Oxid Med Cell Longev (2016) 0.76
Insula Volume and Salience Network Are Associated with Memory Decline in Parkinson Disease: Complementary Analyses of Voxel-Based Morphometry versus Volume of Interest. Parkinsons Dis (2016) 0.76
Long-term neuropsychological sequelae in HIV-seronegative cryptococcal meningoencephalitis patients with and without ventriculoperitoneal shunts: a cine MRI study. Behav Neurol (2015) 0.75
The association among antioxidant enzymes, autoantibodies, and disease severity score in systemic lupus erythematosus: comparison of neuropsychiatric and nonneuropsychiatric groups. Biomed Res Int (2014) 0.75
Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson's Disease. Oxid Med Cell Longev (2017) 0.75